283 related articles for article (PubMed ID: 15308724)
21. Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV.
Payne SL; Fang FD; Liu CP; Dhruva BR; Rwambo P; Issel CJ; Montelaro RC
Virology; 1987 Dec; 161(2):321-31. PubMed ID: 2825406
[TBL] [Abstract][Full Text] [Related]
22. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.
Zhang W; Lonning SM; McGuire TC
J Virol; 1998 Dec; 72(12):9612-20. PubMed ID: 9811694
[TBL] [Abstract][Full Text] [Related]
23. Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.
Craigo JK; Ezzelarab C; Cook SJ; Liu C; Horohov D; Issel CJ; Montelaro RC
PLoS Pathog; 2015 Jan; 11(1):e1004610. PubMed ID: 25569288
[TBL] [Abstract][Full Text] [Related]
24. An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.
Craigo JK; Barnes S; Zhang B; Cook SJ; Howe L; Issel CJ; Montelaro RC
Retrovirology; 2009 Oct; 6():95. PubMed ID: 19843328
[TBL] [Abstract][Full Text] [Related]
25. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.
Payne SL; Pei XF; Jia B; Fagerness A; Fuller FJ
J Virol; 2004 Mar; 78(5):2478-85. PubMed ID: 14963146
[TBL] [Abstract][Full Text] [Related]
26. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
27. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
[TBL] [Abstract][Full Text] [Related]
28. Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia.
Tornquist SJ; Oaks JL; Crawford TB
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2541-8. PubMed ID: 9349475
[TBL] [Abstract][Full Text] [Related]
29. Gag genetic heterogeneity of equine infectious anemia virus (EIAV) in naturally infected horses in Canada.
Nagarajan MM; Simard C
Virus Res; 2007 Nov; 129(2):228-35. PubMed ID: 17767972
[TBL] [Abstract][Full Text] [Related]
30. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
[TBL] [Abstract][Full Text] [Related]
31. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.
Han X; Zou J; Wang X; Guo W; Huo G; Shen R; Xiang W
Viral Immunol; 2010 Oct; 23(5):531-9. PubMed ID: 20883167
[TBL] [Abstract][Full Text] [Related]
32. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.
Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S
Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901
[TBL] [Abstract][Full Text] [Related]
33. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T lymphocytes in protection against equine infectious anemia virus.
McGuire TC; Fraser DG; Mealey RH
Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338
[TBL] [Abstract][Full Text] [Related]
35. Deep sequencing and variant analysis of an Italian pathogenic field strain of equine infectious anaemia virus.
Cappelli K; Cook RF; Stefanetti V; Passamonti F; Autorino GL; Scicluna MT; Coletti M; Verini Supplizi A; Capomaccio S
Transbound Emerg Dis; 2017 Dec; 64(6):2104-2112. PubMed ID: 28299895
[TBL] [Abstract][Full Text] [Related]
36. The determination of in vivo envelope-specific cell-mediated immune responses in equine infectious anemia virus-infected ponies.
Liu C; Cook FR; Cook SJ; Craigo JK; Even DL; Issel CJ; Montelaro RC; Horohov DW
Vet Immunol Immunopathol; 2012 Aug; 148(3-4):302-10. PubMed ID: 22795699
[TBL] [Abstract][Full Text] [Related]
37. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
[TBL] [Abstract][Full Text] [Related]
38. Understanding virus-host dynamics following EIAV infection in SCID horses.
Ciupe SM; Schwartz EJ
J Theor Biol; 2014 Feb; 343():1-8. PubMed ID: 24252283
[TBL] [Abstract][Full Text] [Related]
39. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
Tschetter JR; Byrne KM; Perryman LE; McGuire TC
Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
[TBL] [Abstract][Full Text] [Related]
40. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
